Login

Join for Free!
112478 members
table of contents table of contents

High purity of tumour samples is a necessity for accurate genetic and …


Biology Articles » Biotechnology » Red Biotechnology » Negative selection of chronic lymphocytic leukaemia cells using a bifunctional rosette-based antibody cocktail » References

References
- Negative selection of chronic lymphocytic leukaemia cells using a bifunctional rosette-based antibody cocktail

  1. Staal FJ, Cario G, Cazzaniga G, Haferlach T, Heuser M, Hofmann WK, Mills K, Schrappe M, Stanulla M, Wingen LU, van Dongen JJ, Schlegelberger B: Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks.

    Leukemia 2006, 20:1385-92. 

  2. de Ridder D, van der Linden CE, Schonewille T, Dik WA, Reinders MJ, van Dongen JJ, Staal FJ: Purity for clarity: the need for purification of tumor cells in DNA microarray studies.

    Leukemia 2005, 19:618-27. 

  3. Haslinger C, Schweifer N, Stilgenbauer S, Dohner H, Lichter P, Kraut N, Stratowa C, Abseher R: Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status.

    J Clin Oncol 2004, 22:3937-49.

  4. Falt S, Merup M, Tobin G, Thunberg U, Gahrton G, Rosenquist R, Wennborg A: Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia.

    Blood 2005, 106:681-9.

  5. Stankovic T, Hubank M, Cronin D, Stewart GS, Fletcher D, Bignell CR, Alvi AJ, Austen B, Weston VJ, Fegan C, Byrd PJ, Moss PA, Taylor AM: Microarray analysis reveals that TP53- and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responses.

    Blood 2004, 103:291-300. 

  6. Rosenwald A, Chuang EY, Davis RE, Wiestner A, Alizadeh AA, Arthur DC, Mitchell JB, Marti GE, Fowler DH, Wilson WH, Staudt LM: Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response.

    Blood 2004, 104:1428-34. 

  7. Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson RE, Orchard JA, Davis Z, Stetler-Stevenson M, Raffeld M, Arthur DC, Marti GE, Wilson WH, Hamblin TJ, Oscier DG, Staudt LM: ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.

    Blood 2003, 101:4944-51. 

  8. Huttmann A, Klein-Hitpass L, Thomale J, Deenen R, Carpinteiro A, Nuckel H, Ebeling P, Fuhrer A, Edelmann J, Sellmann L, Duhrsen U, Durig J: Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.

    Leukemia 2006, 20:1774-82. 

  9. Peters CE, Woodside SM, Eaves AC: Isolation of subsets of immune cells.

    Methods Mol Biol 2005, 302:95-116. 


rating: 2.00 from 1 votes | updated on: 29 Nov 2008 | views: 4667 |

Rate article:







excellent!bad…